A telehealth brand can need polished product visuals long before it has a complete photography library. Treatment pages need imagery, campaigns need creative, and launch materials need to present the brand consistently across different formats. Producing every visual through traditional photography can slow that early creative process, especially when a team is still testing its positioning and visual identity.
That is where learning to use AI to create product images can help. Generative AI can help teams develop concepts for injection vials, pill bottles, cream containers, product bundles, and other branded assets while maintaining a shared visual direction.
For telehealth companies, however, speed is only one part of the workflow. A convincing AI-generated medication image can also include incorrect label text, imply an unintended claim, or make a conceptual package look like a real product. The best process therefore combines AI generation with brand controls and human review.
From a Prompt to a Branded Product Asset
Creating a generic product image with AI is relatively simple. Creating a family of product images that consistently looks like one brand requires more structure.
Instead of treating every generation as a separate design project, telehealth teams can establish a repeatable set of visual rules. The product format may change from a vial to a bottle or topical container, but the brand's recognizable elements remain stable.
Those elements might include:
- Exact brand colors and HEX codes
- Font family and weight
- Label colors
- Cap or closure colors
- Product-name placement
- Logo position
- Text alignment
- Background style
- Lighting and shadows
- Camera angle
- Spacing around the product
The result is not simply a collection of attractive images. It becomes a reusable visual system that can support a growing library of marketing assets.
Watch: Generating Product Assets With Bask University
video
This Bask University module demonstrates the process from the prompt onward. It shows how a telehealth brand can define details such as colors, fonts, label text, and backgrounds; generate different product formats; remove backgrounds; and combine individual products into larger branded compositions.
The workflow's value isn't tied to producing one perfect image. It is the ability to reuse the same creative framework as the brand needs additional assets.
Build the Visual Rules Before Generating Images
One of the easiest ways to lose brand consistency is to let the AI make too many creative decisions.
A prompt such as “create a premium telehealth medication bottle” leaves the model to interpret what premium means. It may choose one color palette for the first generation and a completely different design language for the next. Both images can look polished but still feel like they come from different companies. That inconsistency can weaken the broader digital brand strategy a telehealth company is trying to establish.
More specific inputs reduce that variability.
For example, “blue” can become an exact HEX code. “Modern font” can become a defined font family and weight. “Clean background” can become a white background with a soft drop shadow.
This does not guarantee identical results every time, but it creates much stronger constraints for the model to work within.
Separate Fixed Brand Elements From Product Variables
A useful prompt template distinguishes between elements that should remain constant and information that changes from one product to another.
| Element | Usually Fixed | Usually Variable |
|---|
| Brand colors | ✓ | |
| Typography | ✓ | |
| Label style | ✓ | |
| Lighting | ✓ | |
| Background | ✓ | |
| Product format | | ✓ |
| Product name | | ✓ |
| Container type | | ✓ |
| Product-specific text | | ✓ |
| Composition | Sometimes | Sometimes |
With this structure, creating the next asset does not mean rebuilding the prompt from scratch. The team can preserve its approved visual foundation and replace only the variables required for the new product.
Generate a Master Asset Before Building Marketing Creative
It can be tempting to ask AI for a finished advertisement immediately: a branded bottle, styled background, headline area, decorative elements, and campaign composition all in one generation.
A more flexible workflow starts smaller.
Create the product itself first.
Once the container, colors, proportions, label structure, and other visual details are satisfactory, that image can become a master asset. Removing its background creates a transparent version you can reuse in different contexts without asking AI to reconstruct the product every time.
That one asset might later appear on:
- Treatment pages
- Landing pages
- Paid social creative
- Display advertising
- Email campaigns
- Educational graphics
- Organic social posts
- Product comparisons
- Product bundles
This approach also reduces a common generative-AI problem: subtle changes to the product each time you generate a new campaign image.
Review AI-Generated Labels Separately
A visually convincing package can still contain bad information.
Image models may misspell a product name, alter text between generations, introduce strange characters, or add information that was never requested. Small label text is particularly vulnerable because the model is producing an image rather than functioning as a pharmaceutical labeling system.
For a telehealth brand, label QA deserves its own step.
Review:
- Product names and spelling
- Strength or dosage information, if shown
- Product format
- Prescription-related language
- Brand name and logo
- Disclosures
- Claims
- Any text the model introduced itself
The more realistic the generated package looks, the more important this review becomes. A viewer may reasonably interpret a highly realistic vial or bottle as an accurate representation of an actual product.
Treat Compounded Medication Imagery With Extra Care
This distinction matters most when an asset represents a compounded medication.
The FDA states that compounded drugs are not FDA-approved, which means the agency does not verify their safety, effectiveness, or quality before they are marketed through the approval process used for FDA-approved drugs. The agency also notes that compounding can serve an important patient need in certain circumstances. See the FDA's Compounding and the FDA: Questions and Answers for its current explanation.
An AI-generated concept should therefore not introduce packaging, badges, language, or other visual signals that create an inaccurate impression of regulatory status.
The same principle applies more broadly: AI should not decide what legally or clinically belongs on medication packaging. When imagery is intended to depict a real offering rather than a conceptual asset, teams should verify the final representation against the actual product and applicable requirements.

Think About What the Image Implies
Accuracy is not limited to text.
A product image can communicate a message without making an explicit written statement. A vial surrounded by imagery suggesting dramatic weight loss, for example, communicates something very different from the same vial photographed against a neutral background.
The FTC's Health Products Compliance Guidance explains that marketers need to consider both express and implied claims. It also emphasizes the overall impression an advertisement creates, including elements such as product names and imagery.
That creates a useful review question for AI-generated telehealth creative:
What could a reasonable viewer conclude from this image, even if we never wrote it explicitly?
Teams should consider the answer before moving an AI-generated product visual from the creative stage into a live campaign.
The same principle should carry into the brand's broader telehealth marketing strategy, where creative decisions influence trust, acquisition, and conversion.
Turn Individual Images Into Reusable Product Assets
Background removal is a small step that can make an AI-generated image substantially more useful.
Instead of saving only the finished scene the model produced, create a clean, transparent version of the approved product. That transparent asset becomes a building block rather than a one-use image.
A simple production sequence might look like:
Generate → Review → Refine → Remove background → Approve → Save
The approved asset can then move into different designs without changing the underlying product representation.
This also gives designers more control. They can adjust composition, background, spacing, and surrounding creative independently while preserving the reviewed product image.
Create Product Bundles From Approved Assets
Once individual assets are established, they can combine them into larger compositions.
For example, a telehealth brand may want a visual containing a vial, bottle, and topical container for a campaign or category page. Asking an image model to generate all three from scratch in a single complex prompt can introduce inconsistencies in scale, labels, colors, or packaging.
Starting with approved individual assets provides more control.
The workflow becomes:
Individual assets → QA → transparent masters → bundle composition
This approach is particularly useful when the same products need to appear across multiple campaigns. Instead of regenerating them every time, the creative team works from a controlled library.
Keep AI Concepts and Real Product Photography Distinct
Not every AI-generated product image has the same purpose.
Some assets exist to explore a visual direction before a brand launches. Others may be suitable as illustrative marketing creative after review. Still others appear in contexts where patients expect to see the actual product they may receive.
Don't automatically treat those use cases as interchangeable.
A simple internal classification can help:
| Asset Type | Primary Purpose | Review Priority |
|---|
| Concept asset | Brand and creative exploration | Visual direction |
| Approved marketing asset | Campaigns and brand content | Accuracy, claims, brand QA |
| Actual product image | Represents the real product | Accurate product representation |
This distinction becomes increasingly valuable as more people work with the asset library.
Without it, someone can easily download, share, reuse, and eventually publish an early concept without knowing how the image was originally created.
Don't Let AI Become the Claims Reviewer
Generative AI is designed to produce the requested output. You should not expect it to determine whether a healthcare advertisement makes an appropriate claim.
A prompt asking for a persuasive or dramatic product visual may encourage the model to add visual cues that strengthen the marketing message. In a healthcare context, those additions deserve scrutiny.
FTC guidance states that health-related advertising should be truthful and not misleading and that objective product claims require appropriate substantiation. Those principles apply to implied claims as well as explicit ones.
For the creative team, this means an AI image should go through the same claims-conscious review process as other advertising assets. The model introducing a visual element automatically does not make that element neutral.
AI can accelerate creation. Approval remains a human responsibility.
Protect Consistency as the Asset Library Grows
The ability to produce more images can create a new problem: too many brand versions.
One team member changes the blue slightly. Another generates a different label style. A third asks AI to redesign the logo placement. Over time, the asset library can become less consistent, not more efficient.
Maintaining a controlled set of approved inputs helps prevent that drift:
- Logo files
- Brand colors
- Typography
- Label templates
- Product templates
- Background rules
- Prompt templates
- Transparent master assets
- Naming conventions
- Approved export formats
Brand identifiers can also carry intellectual-property considerations. The USPTO explains that trademarks can include words, phrases, symbols, designs, or combinations of those elements that identify the source of goods or services. Its trademark basics provide additional background for teams building and protecting a brand identity.
The goal is not to prevent experimentation. It is to make sure experimentation does not quietly replace the recognizable brand.
A Practical Workflow for AI Product Images
Once the rules are set, the production process doesn't need to be complicated.
Define the asset you need
Start with the intended output rather than opening the image generator immediately. Decide whether you need a vial, bottle, topical container, transparent cutout, bundle, or finished campaign composition.
Use the approved prompt template
Insert the established colors, typography, label structure, background, and other brand controls. This keeps new generations connected to the existing asset family.
Change only the product variables
Update the product format, name, or other approved information while leaving the visual foundation intact.
Generate multiple options
Compare several outputs for proportions, consistency, label quality, artifacts, and realism rather than automatically selecting the first result.
Perform visual and text QA
Zoom in on labels and inspect the entire image. Check both what the asset explicitly says and what it may imply.
Create a transparent master
When useful, remove the background and save a clean version that designers can place into multiple compositions.
Approve and organize
Use clear filenames, folders, and version controls so other team members can identify approved assets without guessing.
Reuse instead of regenerating
Build new campaign creative around approved master assets whenever possible. This is where AI image generation starts functioning as a scalable creative system, not a series of isolated experiments.
How Bask University Makes the Process Repeatable
The Generating Product Assets module in Bask University demonstrates this workflow with reusable prompts and brand variables rather than treating each image as an unrelated generation.
The examples move across several product formats while maintaining a shared visual identity. Brand colors, typography, label structure, backgrounds, and product-specific information can be adjusted, while background removal turns finished generations into flexible assets for later designs.
This approach is particularly relevant to telehealth founders because product imagery is only one piece of building the brand. A company also needs the infrastructure that supports the actual patient experience, from the digital storefront through the operational workflows behind care delivery.
Bask provides the white-label telemedicine platform layer for building that telehealth experience, while Bask University helps founders understand practical launch and growth workflows. Product asset generation fits into that broader process as a way to build the visual side of the brand without confusing creative production with the healthcare infrastructure itself.
Build an Asset System, Not a Folder of AI Images
The biggest advantage of learning to use AI to create product images isn't generating one image quickly. It is that a telehealth brand can develop a repeatable production process around those images.
Start with defined brand rules. Create a reusable prompt structure. Generate individual products. Review labels and implied messages carefully. Save transparent master assets. Then use those approved visuals to create the combinations and campaign materials the business needs.
That process preserves much of AI's speed without giving the model control over decisions that require human judgment.
For telehealth brands, that distinction matters. The best AI product image is not simply the one that looks convincing. It is the one that fits the brand, serves a clear marketing purpose, and has been reviewed closely enough to deserve a place in the real customer experience.
References
- U.S. Food and Drug Administration (FDA). (n.d.). Compounding and the FDA: Questions and answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- U.S. Federal Trade Commission (FTC). (2022). Health products compliance guidance. https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
- U.S. Patent and Trademark Office (USPTO). (n.d.). What is a trademark? https://www.uspto.gov/trademarks/basics/what-trademark